Search Results for

Showing 1 - 10 of 70 results
  1. OCT paper press release

    Embargoed until Dec. 7, 12pm EDT Media contact: Marisa Lavine   +                                                                                                                                                                                                                                New study finds federally-funded technology saved Medicare $9 billion Rockville, Md. — A new study quantifying a 21-fold return on investment suggests an e

  2. Invited speakers

    Invited speakers Bettina Ryll Richard D. Carvajal Invited Speakers Sponsors

  3. Professional Development and Education Committee

    Professional Development and Education Committee Professional Development and Education Committee Description The Professional Development and Education Committee (PDEC) provides the following roles: Identify topics for online learning, including webinars and online courses. Conduct call for proposals, review submissions, and select final organizer(s) and speaker(s) to work with staff to develop and implement through ARVOLearn. Review and finalize selection of member proposals for full an

  4. Board of Trustees

    Board of Trustees The Board of Trustees is comprised of elected members from ARVO's 13 Scientific Sections along with elected and trustee-appointed officers. The president and vice president(s) are elected from within the Board each year. The executive vice president is elected by the general membership to a five-year term and is a voting member of the Board of Trustees. The ARVO executive director serves as an ex officio member of the Board. For more information on Board of Trustee duties,

  5. AMPC Candidates

    All candidate bios and nomination statements are available on the official ballots

  6. Trending topics: Patient engagement

    Trending topics Patients: From consumers to partners Passenger. End user. Spectator. These are terms that many in biomedical research would use to describe the role patients play as a potential therapy winds its way along the development pipeline. Yet, a growing number of patients are no longer content to simply watch and wait as possible life-changing science happens without them.  “Other than providing funding, the patient community hasn’t traditionally been given the opportunity to intera

  7. NEI director's message

    NEI director’s message Updates, challenges, progress and the 50-year celebration Paul A. Sieving, MD, PhD, FARVO  NEI launched the Eyes of Infants with Zika (EIZ) study in June with the help of Brazilian investigators. As you may recall, in summer 2015 epidemiologists observed that Zika virus infection during pregnancy could result in babies with severe microcephaly. In response to this alarming news, NIH mounted a multi-Institute effort to follow a Zika-exposed cohort of pregnant women to s

  8. Journals column

    ARVO Journals Editors-in-chief prepare for new term In May 2016, ARVO members elected editors-in-chief (EICs) for the association’s three journals. The new EICs will officially begin their five-year terms in January 2018. Each recently shared parts of their vision for their respective journals with ARVONews. Donald Hood, PhD, FARVO Columbia University ARVONews: All new editors want to improve their journal. How are you going to go about this? In the statement I submitted when running for edi